ArticleClinical rheumatology2026
Visit adherence and clinical, inflammatory, and patient-reported outcomes in rheumatoid arthritis: a cross-sectional study.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThis study examines how visit adherence influences disease activity, outcomes, and quality of life in rheumatoid arthritis, and suggests recommendations to improve management.
methodsA toal of 216 RA patients diagnosed for at least 1 year were studied. Clinical and physical data were recorded at enrollment. Visit adherence was defined as attending at least 4 outpatient visits per year. Questionnaires (Patient Global, SF-36, HAQ, PUKI, HAD, MAF) and disease activity scores (DAS-28, SDAI, CDAI) were collected to assess associations with visit adherence.
resultsVisit-adherent patients averaged 49.3 ± 14 years; non-adherent patients averaged 55.9 ± 14.7 years. Among women, 93 (70.5%) were adherent; among men, 39 (29.5%) were adherent. Age, gender, education, physical activity, and appointment type affected adherence. Adherence was associated with longer disease duration, delayed diagnosis, medication adherence, osteoporosis, morning stiffness, rheumatoid nodules, erosive joints, and high ESR and CRP (p < 0.001). Visit adherence is key to managing disease, improving outcomes, reducing complications, and improving quality of life.
conclusionThis study demonstrates that patients with higher disease activity, greater inflammation, and clinical symptoms such as morning stiffness are more likely to struggle with adherence to visits. The findings suggest that targeted interventions-such as tailored education, reminders, flexible scheduling, and additional patient support-should be implemented to help these patients adhere to visits. Improving visit adherence may enhance treatment outcomes, reduce complications, and increase quality of life for these patients. Key Points • Low visit adherence in rheumatoid arthritis is associated with higher disease activity, increased inflammatory burden, and poorer quality of life. • Patients with visit non-compliance had significantly worse functional, psychological, and disease activity scores. • Improving regular follow-up adherence may contribute to better disease control and improved clinical outcomes in rheumatoid arthritis.
Indexed as
Identifiers
42834258What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.